Bruce McCarty

Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada.

Part of Perrigo Co. Plc, Draxis Pharmaceutica is a Canadian company that manufactures pharmaceutical products. The company is based in Montréal, Canada. Draxis Pharmaceutica was acquired by Elan Corp. Plc from Deprenyl Research Ltd. on January 23, 2002 for $1 million.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA.